10.680
+0.140
+(1.33%)
At close: January 28 at 12:08:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,888.000
-286,911.000
-120,292.000
-136,790.000
-151,093.000
Investing Cash Flow
-1,036,239.000
-357,728.000
-443,296.000
-212,548.000
-100,166.000
Financing Cash Flow
53,806.000
1,068,260.000
419,317.000
902,141.000
624,203.000
End Cash Position
395,013.000
1,446,403.000
1,023,999.000
1,180,971.000
629,058.000
Capital Expenditure
-177,060.000
-157,713.000
-203,572.000
-135,689.000
-127,747.000
Issuance of Capital Stock
12,135.000
1,030,168.000
423,307.000
951,229.000
620,011.000
Issuance of Debt
87,273.000
74,388.000
33,062.000
26,041.000
52,921.000
Repayment of Debt
-58,381.000
-24,606.000
-463.000
-71,216.000
-28,720.000
Repurchase of Capital Stock
--
--
--
--
-9,460.000
Free Cash Flow
-196,948.000
-444,624.000
-323,864.000
-272,479.000
-278,840.000
12/31/2020 - 12/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LSW.BE Tissue Regenix Group PLC
0.6600
-2.22%
688235.SS BeiGene, Ltd.
190.69
+0.89%
6160.HK BeiGene, Ltd.
138.200
+3.21%
TRX.L Tissue Regenix Group plc
59.00
+1.72%
BRNS Barinthus Biotherapeutics plc
1.0953
+9.53%
2269.HK WuXi Biologics (Cayman) Inc.
18.420
-0.22%
MGTX MeiraGTx Holdings plc
6.29
-2.18%
LEGN Legend Biotech Corporation
38.10
+2.36%
ONC BeiGene, Ltd.
224.99
-0.84%
IMCR Immunocore Holdings plc
32.88
+0.83%